Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-01-07 @ 8:00 PM
Study NCT ID:
NCT01889069
Status:
COMPLETED
Last Update Posted:
2020-08-13
First Post:
2013-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-26
First Submit QC Date:
None
Study First Post Date:
2013-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-05-28
Results First Submit QC Date:
None
Results First Post Date:
2020-08-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-28
Last Update Post Date:
2020-08-13
Last Update Post Date Type:
ACTUAL